Home » Topics » BioWorld Science

BioWorld Science
RSS

Decreased SLC39A1 expression is associated with poor prognosis in HCC

May 13, 2020

GALNT14 GG genotype as prognostic biomarker in PDA

May 13, 2020

Tukysa approved in Switzerland for metastatic HER2-positive breast cancer

May 13, 2020

Sorrento Therapeutics and Mount Sinai partner on antibody cocktail for COVID-19

May 13, 2020

Integrated herpesvirus 6 is pre-eclampsia risk factor

May 13, 2020

Genfit reports phase III interim data on elafibranor in NASH

May 12, 2020

Phase III study of Sarclisa in relapsed multiple myeloma meets primary endpoint

May 12, 2020

FDA clears IND for phase Ib/IIa study of HST-001 for androgenic alopecia

May 12, 2020

Phase I study of BRD4 inhibitor SYHA-1801 begins for advanced solid tumors

May 12, 2020

Ustekinumab efficacy demonstrated in pediatric Crohn's disease patients

May 12, 2020

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...